全文获取类型
收费全文 | 2923篇 |
免费 | 162篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 113篇 |
妇产科学 | 275篇 |
基础医学 | 366篇 |
口腔科学 | 37篇 |
临床医学 | 195篇 |
内科学 | 680篇 |
皮肤病学 | 73篇 |
神经病学 | 104篇 |
特种医学 | 49篇 |
外科学 | 233篇 |
综合类 | 101篇 |
一般理论 | 3篇 |
预防医学 | 152篇 |
眼科学 | 234篇 |
药学 | 233篇 |
中国医学 | 11篇 |
肿瘤学 | 183篇 |
出版年
2024年 | 3篇 |
2023年 | 13篇 |
2022年 | 48篇 |
2021年 | 97篇 |
2020年 | 53篇 |
2019年 | 63篇 |
2018年 | 83篇 |
2017年 | 51篇 |
2016年 | 70篇 |
2015年 | 79篇 |
2014年 | 104篇 |
2013年 | 125篇 |
2012年 | 251篇 |
2011年 | 242篇 |
2010年 | 115篇 |
2009年 | 78篇 |
2008年 | 171篇 |
2007年 | 196篇 |
2006年 | 191篇 |
2005年 | 167篇 |
2004年 | 144篇 |
2003年 | 143篇 |
2002年 | 107篇 |
2001年 | 54篇 |
2000年 | 66篇 |
1999年 | 52篇 |
1998年 | 28篇 |
1997年 | 24篇 |
1996年 | 16篇 |
1995年 | 16篇 |
1994年 | 9篇 |
1993年 | 22篇 |
1992年 | 23篇 |
1991年 | 19篇 |
1990年 | 20篇 |
1989年 | 28篇 |
1988年 | 22篇 |
1987年 | 10篇 |
1986年 | 17篇 |
1985年 | 9篇 |
1984年 | 11篇 |
1983年 | 5篇 |
1981年 | 7篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 6篇 |
1970年 | 4篇 |
1969年 | 4篇 |
1967年 | 3篇 |
1964年 | 2篇 |
排序方式: 共有3091条查询结果,搜索用时 15 毫秒
41.
42.
Kisucka J Chauhan AK Patten IS Yesilaltay A Neumann C Van Etten RA Krieger M Wagner DD 《Circulation research》2008,103(6):598-605
The peroxiredoxin (Prdx) family of antioxidant enzymes uses redox-active cysteines to reduce peroxides, lipid hydroperoxides, and peroxynitrites. Prdx1 is known to be important to protect red blood cells against reactive oxygen species and in tumor prevention. In this study, the role of Prdx1 in inflammation, thrombosis, and atherosclerosis was investigated. Using intravital microscopy, we showed that the number of leukocytes rolling per minute in unstimulated veins was increased by 2.5-fold in Prdx1(-/-) compared to Prdx1(+/+) mice. In Prdx1(-/-) mice, 50% of leukocytes rolled at a velocity <10 mum/sec compared with 10% in Prdx1(+/+) mice, suggesting that adhesion molecule density on the endothelium may have been increased by Prdx1 deficiency. Indeed, endothelial P-selectin, soluble P-selectin, and von Willebrand factor in plasma were increased in Prdx1(-/-) mice compared to Prdx1(+/+) mice, indicating elevated Weibel-Palade body release. In contrast to this excessive endothelial activation, Prdx1(-/-) platelets showed no sign of hyperreactivity, and their aggregation both in vitro and in vivo was normal. We also examined the role of Prdx1 in the apoE(-/-) murine spontaneous model of atherosclerosis. Prdx1(-/-)/apoE(-/-) mice fed normal chow developed larger, more macrophage-rich aortic sinus lesions than Prdx1(+/+)/apoE(-/-) mice, despite similar amounts and size distributions of cholesterol in their plasma lipoproteins. Thus, Prdx1 protects against excessive endothelial activation and atherosclerosis, and the Prdx1(-/-) mice could serve as an animal model susceptible to chronic inflammation. 相似文献
43.
Scotland RS Madhani M Chauhan S Moncada S Andresen J Nilsson H Hobbs AJ Ahluwalia A 《Circulation》2005,111(6):796-803
44.
Anil Rana Jimi Marin Alex Monika Chauhan Gaurav Joshi Raj Kumar 《Medicinal chemistry research》2015,24(3):903-920
Past few decades have witnessed the dawn of new diseases in which cancer is a major problem and the race ensued to eradicate cancer by charting out various effective therapeutic regimens. Circumventing resistance issues and combating the toxicity and selectivity problems are matter-of-concern in cancer treatment. Persistent failure to ensure complete remission and eradication of cancer instigated the researchers to exploit the strategies of combining pharmacophores as targeted therapeutic agents. Momentous improvement in the pharmacokinetic as well as pharmacodynamic profile resulting in the enhancement of bioavailability was seen with the introduction of these pharmacophores. The scope of molecular hybridization can be clearly exemplified through the US-FDA approved estramustine and others such as CUDC-101, CBLC-137, PLX3397, E-3810, and CUDC-907 that are currently in different phases of clinical trials. This review seeks to highlight and discuss anti-proliferative activity of some important hybrid, dual, and multi-targeted pharmacophores reported to date along with their designs, structure activity relationships, scope, and limitations. Further, an emphasis has been made to summarize US-FDA approved as well as drugs currently undergoing clinical trials of anticancer drug development. 相似文献
45.
46.
Shilpa Babbar Suneet P. Chauhan 《The journal of maternal-fetal & neonatal medicine》2015,28(4):431-435
The primary objective of this survey was to ascertain the opinions, practices and knowledge about exercise, including yoga, during pregnancy; the secondary objective to compare the responses among women with body mass index (BMI) <30?kg/m2 versus ≥30?kg/m2. Survey consisted of 20 multiple choice questions assessing demographics and exercise practices, and five questions testing their knowledge about it during pregnancy (ACOG Committee Opinion # 267). Of the 500 surveys distributed, 84% (422) responses were analyzed. While 86% of women responded that exercise during pregnancy is beneficial, 83% felt it was beneficial to start prior to pregnancy, and walking was considered the most beneficial (62%). The majority (64%) of respondents were currently exercising during pregnancy and 51% exercised 2–3 times/week. Among the five questions testing knowledge about prenatal exercise, majority (range 60 to 92%) were aware of ACOG recommendations. About half had a BMI ≥30. Knowledge about benefits of exercise during pregnancy did not differ significantly between obese and non-obese. Yoga was tried significantly more among non-obese, 65% believed it is beneficial, and 40% had attempted yoga before pregnancy. In our population, the majority believes that exercise, including yoga, is beneficial and they are active. 相似文献
47.
2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells 总被引:13,自引:11,他引:13
Chauhan D Catley L Hideshima T Li G Leblanc R Gupta D Sattler M Richardson P Schlossman RL Podar K Weller E Munshi N Anderson KC 《Blood》2002,100(6):2187-2194
2-Methoxyestradiol (2ME2) an estrogen derivative, induces growth arrest and apoptosis in leukemic cells and is also antiangiogenic. In this study, we demonstrate that 2ME2 inhibits growth and induces apoptosis in multiple myeloma (MM) cell lines and patient cells. Significantly, 2ME2 also inhibits growth and induces apoptosis in MM cells resistant to conventional therapies including melphalan (LR-5), doxorubicin (Dox-40 and Dox-6), and dexamethasone (MM.1R). In contrast to its effects on MM cells, 2ME2 does not reduce the survival of normal peripheral blood lymphocytes. Moreover, 2ME2 enhances Dex-induced apoptosis, and its effect is not blocked by interleukin-6 (IL-6). We next examined the effect of 2ME2 on MM cells in the bone marrow (BM) milieu. 2ME2 decreases survival of BM stromal cells (BMSCs), as well as secretion of vascular endothelial growth factor (VEGF), and IL-6 triggered by the adhesion of MM cells to BMSCs. We show that apoptosis induced by 2ME2 is mediated by the release of mitochondrial cytochrome-c (cyto-c) and Smac, followed by the activation of caspases-8, -9, and -3. Finally, 2ME2 inhibits MM cell growth, prolongs survival, and decreases angiogenesis in a murine model. These studies, therefore, demonstrate that 2ME2 mediates anti-MM activity directly on MM cells and in the BM microenvironment. They provide a framework for the use of 2ME2, either alone or in combination with Dex, to overcome drug resistance and to improve outcome in MM. 相似文献
48.
Purpose
To investigate the effect of host immunity (allospecific) and surgical manipulation (non-allospecific) on corneal endothelial cells (CECs) in corneal transplantation.Methods
Draining lymph nodes and grafted C57BL/6 corneas were harvested from syngeneic recipients, allograft acceptors, and allograft rejectors (BALB/c) 1, 3, and 8 weeks after transplantation. We analyzed CEC apoptosis using an ex vivo cornea-in-the-cup assay, and visualized cell-to-cell junctions using immunohistochemical staining (ZO-1). Automatic cell analysis using Confoscan software was used to measure CEC density as well as changes in CEC morphology by quantifying the coefficient of variation in cell size (polymegethism) and shape (pleomorphism).Results
The cornea-in-the-cup assay showed that allogeneic acceptor T cells and to an even greater extent rejector T cells (but not syngeneic T cells) induced CEC apoptosis. CEC density after corneal transplantation was significantly reduced in allogeneic acceptors compared with syngeneic grafts (P<0.001), and CEC density was even further reduced in the allo-rejector group compared with the allo-acceptor group. Allogeneic grafts showed a greater increase in the coefficient of variation in cell size (polymegethism) when compared with syngeneic grafts 1 week after transplantation (P=P<0.001). However, pleomorphism was not significantly different between syngeneic and allo-acceptor grafts, indicating that polymegethism (but not pleomorphism or cell density) is a sensitive indicator of the effect of alloimmunity on CECs.Conclusions
Our data demonstrate that host alloimmunity rather than surgical manipulation alone is the major cause of CEC damage in corneal transplantation, and such morphologic changes of CECs can be detected before the clinically visible onset of allograft rejection. 相似文献49.
Suneeta Dubey Vijeta Sharma Anugya Agrawal Lokesh Chauhan Gordon Douglas 《Saudi Journal of Ophthalmology》2015,29(2):103-108
Purpose
To evaluate the safety and efficacy of Ahmed glaucoma valve (AGV) implantation in refractory glaucoma in Northern Indian eyes.Background
The success rate of trabeculectomy remains low in cases of refractory glaucoma even with the use of antifibrotics. Glaucoma drainage devices have proven to be more efficacious in reducing intraocular pressure (IOP) in these glaucomas.Methods
Retrospective records of 55 consecutive patients who underwent AGV implantation at Dr. Shroff’s Charity Eye Hospital, New Delhi, India from January 2003 to December 2012 were reviewed. Pre-operative data included age, gender, eye laterality, specific diagnosis, number of anti-glaucoma medications, number of prior incisional surgeries, visual acuity and IOP on medical treatment. Postoperative data included visual acuity and IOP on day one, 1 week, 1 month, 3 months, 6 months, 1 year and yearly thereafter, number of anti-glaucoma medications, any complication or additional surgical intervention required. Success was defined as IOP >5 and <22 mmHg with or without treatment.Results
Mean IOP decreased from 39.71 ± 8.99 pre-operatively to 17.52 ± 5.72 mmHg at last follow-up (p < 0.001) and number of medications reduced from 3.27 ± 0.84 to 1.25 ± 0.88 (p < 0.001). Visual acuity remained within one Snellen line or improved at last follow-up in 47 cases (85.4%). The cumulative probability of success was 85.45% at 1 year and 79.63% at 3 years. The incidence of post-operative complications was 25.45%.Conclusion
AGV implantation has proven to be safe and is effective in controlling IOP in refractory glaucoma in Northern Indian eyes. 相似文献50.
S.K. Kiran Achhelal Pasi Satish Kumar Gudadappa S. Kasabi Prabhakara Gujjarappa Aakash Shrivastava Sanjay Mehendale L.S. Chauhan Kayla F. Laserson Manoj Murhekar 《Emerging infectious diseases》2015,21(1):146-149
We investigated a Kyasanur Forest disease outbreak in Karnataka, India during December 2013–April 2014. Surveillance and retrospective study indicated low vaccine coverage, low vaccine effectiveness, and spread of disease to areas beyond those selected for vaccination and to age groups not targeted for vaccination. To control disease, vaccination strategies need to be reviewed. 相似文献